Fiona Copeland
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial.
Journal: Thorax
Published: November 27, 2025
Hypertonic Saline or Carbocisteine in Bronchiectasis.
Journal: The New England journal of medicine
Published: September 29, 2025
Incidence and predictors of self-reported pulmonary exacerbations in primary ciliary dyskinesia: an international prospective cohort study.
Journal: ERJ open research
Published: May 21, 2025
Incidence and Severity of SARS-CoV-2 Infections in People With Primary Ciliary Dyskinesia.
Journal: International journal of public health
Published: November 04, 2022
The Impact on Parents of Diagnosing PCD in Young Children.
Journal: Journal of clinical medicine
Published: June 13, 2022
COVID-19 Vaccinations: Perceptions and Behaviours in People with Primary Ciliary Dyskinesia.
Journal: Vaccines
Published: November 08, 2021
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial.
Journal: Trials
Published: January 14, 2019
Accuracy of High-Speed Video Analysis to Diagnose Primary Ciliary Dyskinesia.
Journal: Chest
Published: October 03, 2018
Diagnosing primary ciliary dyskinesia: an international patient perspective.
Journal: The European respiratory journal
Published: December 02, 2015
Overcoming challenges in the management of primary ciliary dyskinesia: the UK model.
Journal: Paediatric respiratory reviews
Published: December 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026